SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
-14.94%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.83B
AUM Growth
-$682M
(-19%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
486
New
59
Increased
45
Reduced
264
Closed
40
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$29.7M |
| 2 |
TripAdvisor
TRIP
|
+$29.7M |
| 3 |
Estee Lauder
EL
|
+$27.9M |
| 4 |
UnitedHealth
UNH
|
+$23.8M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$23.2M |
Top Sells
| 1 |
Sysco
SYY
|
+$60.5M |
| 2 |
Intuit
INTU
|
+$48.1M |
| 3 |
Baxter International
BAX
|
+$33M |
| 4 |
Hilton Worldwide
HLT
|
+$24.8M |
| 5 |
Salesforce
CRM
|
+$20M |
Sector Composition
| 1 | Technology | 29.28% |
| 2 | Healthcare | 16.08% |
| 3 | Consumer Discretionary | 15.15% |
| 4 | Industrials | 13.19% |
| 5 | Financials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
James River Group
JRVR
$247M
| $411K | 0.01% |
+11,240
| New | +$411K |
|
|
ARRY
202
DELISTED
Array Biopharma Inc
ARRY
| $389K | 0.01% |
27,320
-600
| -2% | -$8.54K |
|
203
Qualys
QLYS
$4.88B
| $386K | 0.01% |
+5,160
| New | +$386K |
|
204
Emergent Biosolutions
EBS
$403M
| $372K | 0.01% |
6,274
-103
| -2% | -$6.11K |
|
205
Chord Energy
CHRD
$5.9B
| $368K | 0.01% |
66,576
+64,039
| +2,524% | +$354K |
|
206
Travel + Leisure Co
TNL
$4.1B
| $368K | 0.01% |
10,100
| – | – |
|
207
Marcus & Millichap
MMI
$1.28B
| $365K | 0.01% |
10,630
-13,650
| -56% | -$469K |
|
|
CBM
208
DELISTED
Cambrex Corporation
CBM
| $363K | 0.01% |
+9,610
| New | +$363K |
|
209
Ligand Pharmaceuticals
LGND
$3.23B
| $343K | 0.01% |
4,056
-160
| -4% | -$13.5K |
|
210
Tenet Healthcare
THC
$17B
| $336K | 0.01% |
19,631
-65,250
| -77% | -$1.12M |
|
|
BSTC
211
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $334K | 0.01% |
5,511
-633
| -10% | -$38.4K |
|
212
First Community Bankshares
FCBC
$693M
| $302K | 0.01% |
9,589
-1,325
| -12% | -$41.7K |
|
|
PES
213
DELISTED
Pioneer Energy Services Corp.
PES
| $302K | 0.01% |
245,230
-6,050
| -2% | -$7.45K |
|
214
Central Pacific Financial
CPF
$835M
| $296K | 0.01% |
+12,140
| New | +$296K |
|
215
Ennis
EBF
$475M
| $292K | 0.01% |
15,168
-20
| -0.1% | -$385 |
|
|
ICPT
216
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $285K | 0.01% |
2,830
-100
| -3% | -$10.1K |
|
217
OFG Bancorp
OFG
$1.97B
| $280K | 0.01% |
16,987
-2,030
| -11% | -$33.5K |
|
218
World Acceptance Corp
WRLD
$937M
| $279K | 0.01% |
2,730
-130
| -5% | -$13.3K |
|
219
Lantheus
LNTH
$3.65B
| $277K | 0.01% |
17,715
-22
| -0.1% | -$344 |
|
220
Tilly's
TLYS
$60M
| $268K | 0.01% |
24,705
-85,770
| -78% | -$930K |
|
221
Repligen
RGEN
$6.79B
| $261K | 0.01% |
4,956
-102
| -2% | -$5.37K |
|
222
Ultragenyx Pharmaceutical
RARE
$3.04B
| $260K | 0.01% |
5,970
-100
| -2% | -$4.36K |
|
223
US Physical Therapy
USPH
$1.29B
| $253K | 0.01% |
2,473
-300
| -11% | -$30.7K |
|
|
BPMC
224
DELISTED
Blueprint Medicines
BPMC
| $251K | 0.01% |
4,650
-100
| -2% | -$5.4K |
|
|
CCXI
225
DELISTED
ChemoCentryx, Inc.
CCXI
| $250K | 0.01% |
22,897
-3,550
| -13% | -$38.8K |
|